Katherine Czysz
Overview
Explore the profile of Katherine Czysz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pistollato F, Bal-Price A, Coecke S, Parvatam S, Pamies D, Czysz K, et al.
Reprod Toxicol
. 2022 Jun;
112:36-50.
PMID: 35697279
The advent of the technology to isolate or generate human pluripotent stem cells provided the potential to develop a wide range of human models that could enhance understanding of mechanisms...
2.
Gurevich I, Burton S, Munn C, Ohshima M, Goedland M, Czysz K, et al.
Biol Open
. 2020 Dec;
9(12).
PMID: 33268331
Non-alcoholic fatty liver disease (NAFLD) affects 30-40% of adults and 10% of children in the US. About 20% of people with NAFLD develop non-alcoholic steatohepatitis (NASH), which may lead to...
3.
Gintant G, Kaushik E, Feaster T, Stoelzle-Feix S, Kanda Y, Osada T, et al.
Regul Toxicol Pharmacol
. 2020 Aug;
117:104756.
PMID: 32822771
Human stem cell-derived cardiomyocytes (hSC-CMs) hold great promise as in vitro models to study the electrophysiological effects of novel drug candidates on human ventricular repolarization. Two recent large validation studies...
4.
Huang K, Reebye V, Czysz K, Ciriello S, Dorman S, Reccia I, et al.
Mol Ther Nucleic Acids
. 2019 Dec;
19:361-370.
PMID: 31877412
Non-alcoholic fatty liver disease (NAFLD) culminates in insulin resistance and metabolic syndrome. Because there are no approved pharmacological treatment agents for non-alcoholic steatohepatitis (NASH) and NAFLD, different signaling pathways are...
5.
Hosoya M, Czysz K
Cells
. 2016 Dec;
5(4).
PMID: 28009813
Despite continuous efforts to improve the process of drug discovery and development, achieving success at the clinical stage remains challenging because of a persistent translational gap between the preclinical and...
6.
Czysz K, Minger S, Thomas N
PLoS One
. 2015 Feb;
10(2):e0117689.
PMID: 25659159
Background: Definitive endoderm (DE) is one of the three germ layers which during in vivo vertebrate development gives rise to a variety of organs including liver, lungs, thyroid and pancreas;...